FDA OKs Philips’ ElastQ Imaging device

Royal Philips’ ElastQ Imaging device earned market clearance from the Food and Drug Administration.

Advertisement

ElastQ aids in the diagnosis of various liver conditions, including hepatitis B and C, liver cancer and cirrhosis.

The device uses shear wave elastography to assess soft liver tissue for stiffness — a sign of issues with the organ — without the need for a liver biopsy.

ElastQ offers a larger field of vision, color-coded quantitative assessment of the tissue stiffness, and real-tine feedback and intelligent analysis, according to a news release.

More articles on supply chain:

Bernie Sanders introduces drug importation bill to lower medicine costs: 5 takeaways
Drug spending rose faster under ACA plans than other health plans
FDA: Drug manufacturing at Pfizer’s Kansas plant is ‘out of control’

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

  • Abbott has launched an updated version of its Oncodetect blood test, which helps clinicians determine whether cancer remains in patients…

  • Becker’s asked supply chain leaders: If you had an extra $1 million for your supply chain budget, where would it…

  • As hospitals redefine the role of supply chain leaders to focus on enterprise strategy, digital transformation and resilience, health systems…

Advertisement

Comments are closed.